Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 14, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

September 30, 2025

Conditions

Systemic Lupus Erythematosus (SLE)

Interventions

BIOLOGICAL

BRL-301

Single dose of Allogeneic Anti-CD19 CAR T cells will be infused

Trial Locations (1)

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou